CTLE

Nano Labs Corp.

OTCQB: CTLE

Company Website

Let’s Make Some Money!!

ABOUT THE COMPANY

Nano Labs is a new public company founded in 2012, with an infrastructure stemming from 30 years of research and development in nanotechnology, resulting from more than 500 published research papers, patents, and prototypes - all managed by a motivated team of seasoned and celebrated nanotechnology experts.

Their R&D team of scientists, designers, and engineers are set to bring innovation and creativity to new levels throughout many industry sectors. The teams goal is single-minded: to create a portfolio of products highlighting superior growth opportunities in innovation, sustainability, and emerging markets. At the same time, Nano Labs business and marketing professionals are poised to work with industry partners with the aim of bringing innovative product solutions immediately to market. Their objective is not simply to make products better, but to build businesses - and industries.

Technologies:

Nano Labs has signed an agreement to produce Pol-Ec Tecnosoil. The Tecnosoil when applied to sand, earth or clay turns the surface to durable cement.

Pol-Ec Tecnosoil can be used to build cement roads without the use of aggregates or concrete. This process reduces infrastructure cost substantially. For example, a client would be able to complete a driveway of 10ft. by 20ft. with only 4 gallons of product! Pol-Ec Tecnosoil will be sold at major retailers such as: Home Depot, Rona, Lowe's & Wal-Mart stores for $199.99 per 4 gallons container.

Pol-Ec Tecnosoil has already established a name for itself in the industry, as it has already been used for the foundation & parking lot for a Wal-Mart store from beach sand in Bahia, California.

Nano Labs will globally distribute to the construction industry through major retail box stores.

Awards:

• Ministry of Economy - Award 2012 as the best High Tech Company Incubated
• 5th National Green Company in Cleantech Challenge 2012
• International Proyect Selected by REDEMPRENDIA for the 3rd Forum Investors in Madrid Espana 2012

Partners

Nano Labs & Polec Industries joint venture collaboration agreement for the manufacture, distribution, marketing of Polec's technology & product.	CIATEQ, AC, Advanced Technology Center to develop projects, manufacture and produce, the Company's proprietary nanotechnology prototypes and products.

 

Our beliefs in partnership

Nano Labs is inviting interested parties to explore our unique capabilities and the potential of nanotechnology as an industry . one that holds all the promise in the world, simply because it involves scientific applications with all the potential to effect just about every industry and consumer good on the planet. We share faith in nanotechnology and our business through core beliefs:

• We believe that for the private investor, there is the potential for what could be significant returns.

• We believe that for government and academia, there is the opportunity to expand knowledge through advanced research and development opportunities.

• We believe that for industry and manufacturing, there is the promise for improved products, systems, and processes.

Our innovative products and services are available for licensing by category and/or by territory. We look for long-term relationships with key licensing and distribution partners. This may include assigning patents, licensing patents for a field of use, technology transfer, copyrights, royalty agreements, buying a product line, and other methods. We perform thorough tests and provide quality assurance before licensing. As well, we design our partner programs to include milestones and performance-based metrics to maximize the value of these programs.

Methods Of Collaboration

We offer a number of ways for companies, organizations and governments to work with us. Our collaborative vehicles include strategic, commercial, and joint-venture programs.

• Our Strategic Partnerships focus on promoting partnerships with academic and government entities to further the development of nanotechnology, including, for example, activities in which we sponsor research by partners.

• Our Commercial Partnerships focus on the industrial commercialization of our products and the licensing of a diverse range of our in-house, intellectual property assets to create new products for mass commercialization.

• Our Joint Ventures focus on cooperative financial investments to commercialize new products and channels.

Nano Labs Corp. (CTLE)

+ Portfolio

0.0460+0.0085 (+22.67%) 3:58P EDT (OTHER OTC)

Detailed Opinion as of Wed, Sep 3rd, 2014 

Detailed Opinion

Show Signal Strength and Direction

Composite Indicators	Signal
TrendSpotter	Buy
Short Term Indicators
7 Day Average Directional Indicator	Buy
10 - 8 Day Moving Average Hilo Channel	Buy
20 Day Moving Average vs Price	Buy
20 - 50 Day MACD Oscillator	Buy
20 Day Bollinger Bands®	Buy
Short Term Indicators Average: 100% Buy

Medium Term Indicators
40 Day Commodity Channel Index	Buy
50 Day Moving Average vs Price	Buy
20 - 100 Day MACD Oscillator	Buy
50 Day Parabolic Time/Price	Buy
Medium Term Indicators Average: 100% Buy
50-Day Average Volume - 718,465
Long Term Indicators
60 Day Commodity Channel Index	Buy
100 Day Moving Average vs Price	Buy
50 - 100 Day MACD Oscillator	Buy
Long Term Indicators Average: 100% Buy
100-Day Average Volume - 459,058
Overall Average: 100% Buy
Price Support Pivot Point Resistance 0.0465 0.0296 0.0390 0.0484

Thursday, August 21, 2014

• Nano Labs Signs Joint Venture Agreement with POLECAccesswire (Thu, Aug 21)

Wednesday, August 20, 2014

• NANO LABS CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online (Wed, Aug 20)

Friday, August 15, 2014

• NANO LABS CORP. Files SEC form 8-K, Unregistered Sale of Equity Securities, Financial Statements and ExhibitsEDGAR Online (Fri, Aug 15)

Tuesday, July 22, 2014

• NANO LABS CORP. FinancialsEDGAR Online Financials (Tue, Jul 22)

Monday, June 30, 2014

• NANO LABS CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online (Mon, Jun 30)

Tuesday, May 20, 2014

• NANO LABS CORP. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Tue, May 20)

Monday, April 28, 2014

• NANO LABS CORP. Files SEC form 8-K/A, Changes in Registrant's Certifying AccountantEDGAR Online (Mon, Apr 28)

Wednesday, April 23, 2014

• NANO LABS CORP. Files SEC form 8-K, Termination of a Material Definitive Agreement, Financial Statements and ExhibitsEDGAR Online (Wed, Apr 23)

Friday, March 7, 2014

• Nano Labs Shareholder UpdateMarketwired (Fri, Mar 7)
• NANO LABS CORP. Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in Directors or PrincipalEDGAR Online (Fri, Mar 7)

Wednesday, March 5, 2014

• Nano Labs Announces Resignation of Dr. Victor CastanoMarketwired (Wed, Mar 5)

Tuesday, February 25, 2014

• NANO LABS CORP. Files SEC form 10-K/A, Annual ReportEDGAR Online (Tue, Feb 25)

Tuesday, February 18, 2014

• NANO LABS CORP. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Tue, Feb 18)

Wednesday, January 22, 2014

• NANO LABS CORP. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and ExhibitsEDGAR Online (Wed, Jan 22)

Monday, January 13, 2014

• Nano Labs Signs Letter of Intent With Polec to Advance Proprietary Technology to Address the Construction Industry's Need for Low-Cost, Self-Sustainable, and Scalable Construction MaterialMarketwired (Mon, Jan 13)

AXXE

AXXESS PHARMA INC.

OTCPK:  (AXXE)

COMPANY WEBSITE

About Us

Axxess Pharma: a focused healthcare company dedicated to providing a wide range of products to improve the lives of patients and consumers worldwide.

We believe action defines leadership.

Our 23 wholly-owned prescription and non-prescription products are targeted to improve health-related conditions including several forms of iron deficiency, bone loss, rheumatoid arthritis, migraine headaches, urinary tract infections, infant cradle cap, joint pain and much more. Axxess Pharma intends to market these products with affordable pricing and widespread availability. Our company will continue to tap the well of innovation to develop ever-more effective and affordable treatment options for the patients we serve, and also foster innovation in education, leadership and advocacy.

Personal passion concerning the well-being of chronic illness sufferers is a major driving force and at the heart of our company. Affordable, proven, prescription and non-prescription products are a critical component to our company Business Plan. We balance environmental impact, social contribution, and financial results. Axxess Pharma is publicly traded on the US stock exchange under the ticker symbol: AXXE.

Products

Prescription Products
Britical	Vivol
Gravergol	Soropon
Somnol	Kemsol
Lactrose	Niaxx
Urasal	Monurol
Axspaz	Hydraxx
Non-Prescription Products
Triferex Syrup	Hydraxx 2%
Triferex Pediatric Syrup	Hydraxx Serum
Potassium Chloride liquid	Hydraxx Serum Eyes
Calcium Citrate with VitaminD	Kemsol for Scleroderma
Soropon Shampoo	Triferex Capsules
Hydraxx 1%

• High-dose oral iron supplement
• Low side-effect oral iron
• Severe anemia oral iron treatment
• Oral iron with erythropoietin
• Triferex the original high-dose oral iron supplement

• Anemia and high-dose oral iron
• Vegetarians and high-dose oral iron
• Dialysis and high-dose oral iron
• High-dose oral iron vs. Intravenous iron
• Compliance issues in high-dose oral iron

• Headache remedies
• Migraine treatments
• Treatment for migraines with nausea
• Migraine medicines
• Low-cost and effective migraine treatments

• Cradle Cap remedies
• Severe dandruff treatments
• Cradle Cap shampoo
• Seborrhoeic dermatitis treatments
• Soropon Shampoo

Management

Daniel Bagi, M.D., President is a senior executive physician with 20+ year’s international experience in the medical device/pharmaceutical industry, with an emphasis on Product Development, Business Development and licensing. Expertise in product development as it pertains to clinical development for commercial use; medical affairs and clinical research, specifically oncology and gynecologic topical women’s health products. Good knowledge of international regulatory standards. Secured numerous license deals internationally, between North American pharma companies and local partners. Extensive experience presenting to financial institutions, regulatory agencies, and potential pharmaceutical partners.

Neil Mellor, Senior VP Sales, has over 25 years of pharmaceutical experience both in Canada and in Europe. Neil has worked for large companies such as Merck, GSK and Pfizer and has also worked with medium-sized pharma companies such as Solvay Pharma. Neil has spent the majority of his background in sales, marketing and business development and has been involved with over thirty products in numerous therapeutic areas. Neil brings a great deal of first-hand experience in commercializing products. In addition, during 2008 Neil was President of the Canadian Healthcare Licensing Association (CHLA) and currently serves as a CHLA Board member. From 1999 to 2004 Neil was Senior Product Manager for Pantoloc®, a proton pump inhibitor used to treat heartburn. During this time Pantoloc exceeded $200m in annual sales and was listed by IMS as the fourth largest pharmaceutical product in Canada. Prior to Solvay, Neil spent 3 years working with Pharmacia Consumer Healthcare (now Pfizer) in Sweden working in International marketing for the brand Nicorette®.

Stephen Taylor, Investor/Business Relations: CEO/Pres. of Taylor Capitol, Inc., has provided Investor Relation services for years with a prior background in equity research and investment banking in the Wall Street area. Stephen Taylor possesses a deep network of connections in the investment community. This network ranges from retail brokers, fund managers, wealth managers, Wall Street analysts, investment bankers, private equity firms and senior level management consultants.

 Partners

Axxess Pharma Inc. Signs Exclusive World-Wide License to Market and Sell TapouT Brand Vitamins & Minerals Pain Relief and Muscle Recovery Products.

TAPOUT website

TapouT is a leading mixed martial arts apparel and lifestyle brand. The company was started by founder Charles “Mask” Lewis Jr., and has since become a pioneer of the MMA movement. TapouT represents the biggest MMA superstars and fans, outfitting them in the hottest apparel for men, women and children. The TapouT lifestyle aims to inspire people to reach their goals and know that anything is possible if they “Simply Believe.”

AXXE Security Details

Share Structure

Market Value1	9,257,100	a/o Aug 29, 2014
Shares Outstanding	47,717,009	a/o Aug 12, 2014
Float	Not Available
Authorized Shares	100,000,000	a/o Feb 21, 2014

• Axxess Pharma to Market Latest All-Natural TapouT Products to Over 50,000 US Military Personnel at Fort Hood, Texas on November 1, 2014Marketwired(Wed, Aug 27)
• Axxess Pharma Inc. Announces US Military (AAFES) Re-Ordering TapouT Product Line at Accelerated RateMarketwired(Thu, Aug 21)
• Axxess Pharma Reports Increased Global Sales Fueled by Aggressive Social Media Marketing, Additional Distributor Relationships and Celebrity Athlete SponsorshipsMarketwired(Tue, Aug 19)
• Axxess Pharma, Inc. Targets Celebrity Athlete Fan Base and Retail Customer Base Through Aggressive, Targeted Online Social Media CampaignMarketwired(Tue, Aug 12)
• Axxess Pharma Announces TapouT Product Line Now Approved by Australian Regulatory Authority: TGAMarketwired(Tue, Aug 5)
• AXXESS PHARMA INC. FinancialsEDGAR Online Financials(Wed, Jul 30)
• Axxess Pharma Inc. Secures $2 Million USD in Financing to Fulfill Increased Rate of Purchase OrdersMarketwired(Wed, Jul 30)
• Axxess Pharma Announces Audited Financials and S-1 Registration Statement Now Filed With SEC for Up-Listing to Over The Counter Bulletin Board (OTC: BB) Stock ExchangeMarketwired(Mon, Jul 28)
• Axxess Pharma and AllStar Health Brands to Meet Additional Distributors at World Renowned 2014 Olympia's Fitness & Performance ExpoMarketwired(Wed, Jul 23)
• Axxess Pharma Announces Financial Audits and Form S-1 to Be Filed With SEC Within One Week for Fully Reporting StatusMarketwired(Thu, Jul 17)
• Axxess Pharma Inc. Announces US Military (AAFES) Quickly Increasing Rate of Purchase Orders for TapouT Line of ProductsMarketwired(Wed, Jul 16)
• Axxess Pharma Becomes Primary Sponsor for Cole Whitt at New Hampshire Motor Speedway and Phoenix International RacewayMarketwired(Thu, Jul 10)
• Axxess Pharma Announces Strong Interest From International Distributors at the UFC Fan Expo(R) EventMarketwired(Tue, Jul 8)
• Axxess Pharma Inc. Receives Additional Purchase Order From US Military (AAFES) for TapouT Line of ProductsMarketwired(Tue, Jul 1)
• Axxess Pharma Reports VP of Business Development of ABG TapouT Reiterates AXXE Is Legal Licensee of TapouT BrandMarketwired(Thu, Jun 26)

NGMC

NGMC 

NEXT Energy Corp OTCQB (NGMC)

NGMC is our Medical Cannabis Alert for Monday.  This is a company that when it first announced its entrance into the Medical Cannabis Industry in march, the stock literally exploded for 600% gains.  What happened next was a nice healthy pullback.  We think now that the market has recuperated from the shock of that transition from oil and gas to medical cannabis that the gains are going to resume!!  This is truly a ground floor opportunity and stocks in this sector are flying high.  

The Marijuana Industry is Set to Soar 

The marijuana industry is projected to see massive growth in coming years. 

 

U.S. retail cannabis sales are forecast to rise more than five-fold over the next five years, from an estimated 2.2-2.6B in 2014 to 7.4-8.2B in 2018, according to new financial data released today in the 2014 edition of the Marijuana Business Factbook. 

 

NGMC is set to take advantage of this amazing projected growth in Marijuana Industry. 

 

The NGMC Board of Directors has recently approved a plan to redirect resources and to focus its core business on the fast growing medical marijuana industry. The Company plans to focus on the acquisition of retail and cultivation licenses throughout North America, as well as the development of a national brand.

 

So as you can see, these are exciting times for NGMC and the entire industry.

 

Make sure you don't miss the action tomorrow at the opening bell, and let's see if we can bank to start the week off on a high note.

NextGen Cannabis Consulting Details Compliance And Accountability Systems Built Into Its Hollywood, California, Medical Marijuana Dispensary

FAIRFAX, Va., June 11, 2014 /PRNewswire via COMTEX/ -- Next Generation Energy Corp. (OTCQB:NGMC) and its wholly owned subsidiary, NextGen Cannabis Consulting LLC, announced today that BioTrackTHC(TM) has been selected as software partner for the Company's DMS (Dispensary Management System).

NextGen Cannabis Consulting LLC provides dispensary management services to the medical marijuana industry including staffing, IT, security, financial, legal and advisory services.

Darryl Reed, Next Generation CEO, stated that "our technical team evaluated numerous dispensary management software products and chose BioTrackTHC(TM) as the clear choice to add to our suite of DMS services. BioTrackTHC(TM) is a fully featured, easy to use, seed to sale solution with grow house/plant management, inventory management, customizable point of sale functionality and a feature rich suite of state and local regulatory agency compliance reporting."

NextGen Cannabis Consulting recently installed BioTrackTHC(TM) in its dispensary, Highway 2 Health, under construction in Hollywood, which is scheduled to open within several weeks with a grand opening scheduled the first week in July. "The technical team reported that the installation was flawless and they experienced excellent support from BioTrackTHC engineers who installed and tested the application remotely," said Mr. Reed. NGMC plans to utilize the BioTrackTHC(TM) software in future dispensary locations as well.

"We are instituting a level of compliance and accountability not typically seen in California. With sparse regulatory guidance and minimal internal dispensary controls, NGMC is going above and beyond what is required and instituting first-of-its-kind practices in this market," NGMC's CEO said.

READ FULL PRESS RELEASE HERE

NGMC Is On The Top Tier OTCQB Of Marijuana Companies, which Is The Highest Level A Company Can Attain On The OTC Exchange.  Many other marijuana companies trade on the Pinksheets, which is a lower ranking. 

NGMC’s float is insanely small for an mj stock, especialy when compared to many others trading many, MANY Times Higher!

Despite the risks, marijuana has been the hottest thing on the street, and has the potential to propel any stock

Now that NGMC has entered the hottest market around, we could be in for some explosive fireworks.

 

Friday, July 11, 2014

• Next Generation Management Corp. (Formerly Next Generation Energy Corp.) Announces Name ChangePR Newswire( (Fri, Jul 11)

Wednesday, July 9, 2014

• Next Generation Management Corp. opens medical marijuana dispensary in HollywoodPR Newswire( (Wed, Jul 9)

Wednesday, June 11, 2014

• NextGen Cannabis Consulting Details Compliance And Accountability Systems Built Into Its Hollywood, California, Medical Marijuana DispensaryPR Newswire( (Wed, Jun 11)

Monday, April 28, 2014

• CannabisFN Weekly: 4/20 Brings Cannabis Further into the MainstreamAccesswire( (Mon, Apr 28)

Friday, April 25, 2014

• NextGen Cannabis Consulting Opening a Medical Marijuana Dispensary In Hollywood, CAPR Newswire( (Fri, Apr 25)

Wednesday, April 16, 2014

• NextGen Cannabis (OTCQB: NGMC) Announces Retention of Law Firm With Broad Medical Marijuana Industry BackgroundPR Newswire( (Wed, Apr 16)

Monday, March 31, 2014

• Nextgen Cannabis Consulting, LLC, a Wholly Owned Subsidiary of Next Generation Energy Corp., Announces LOI To Purchase 20 Percent of Los Angeles Medical Marijuana DispensaryPR Newswire( (Mon, Mar 31)

Wednesday, March 19, 2014

• NextGen Cannabis Consulting LLC, Wholly Owned Subsidiary of Next Generation Energy Corp. (OTCQB:NGMC), Enters Into Agreement to Open Flagship Medical Marijuana Dispensary in Southern CaliforniaPR Newswire( (Wed, Mar 19)

Friday, March 7, 2014

• Next Generation Energy Corp. Announces Significant Shift in its Business Operations to Focus on Booming Medical Marijuana IndustryPR Newswire( (Fri, Mar 7)